Day: July 11, 2024

The eight-week, online camp celebrates an Atari summer tradition with games and activities NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) — Atari® — one of the world’s most iconic consumer brands and interactive entertainment producers — today announced open enrollment for Atari Summer Camp, an eight week online celebration of retro gaming and everything 1980s. Anyone can join during the camp season by signing up at atari.com. Partner events and virtual field trips will be announced over the course of the four, two week sessions including special activations with Codecademy, Coinbase, Nifty Island, Rollercoaster Tycoon and more. Participants will log into a personalized Atari Club page and gain access to a Camp portal modeled after an Atari ST desktop that is hosted by an AI camp director. Programming will take place in Discord,...

VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced that it has completed the sale of its remaining 77% interest in the steelmaking coal business to Glencore plc. Teck received total cash proceeds of US$7.3 billion, subject to customary closing adjustments. About TeckTeck is a leading Canadian resource company focused on responsibly providing metals essential to economic development and the energy transition. Teck has a portfolio of world-class copper and zinc operations across North and South America and an industry-leading copper growth pipeline. We are focused on creating value by advancing responsible growth and ensuring resilience built on a foundation of stakeholder trust. Headquartered in Vancouver, Canada, Teck’s shares are listed...

Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in preclinical models of difficult-to-treat KRAS-mutated non-small cell lung cancer (NSCLC) Results also highlight that, in contrast to mutant-selective RAS inhibition, broad-spectrum, reversible RAS-GTP inhibition with a RAS(ON) multi-selective inhibitor alone drove durable anti-tumor activity in these models with infrequent resistance occurrence and the potential for emergence of rare persister, slow cycling cells REDWOOD CITY, Calif., July 11, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the publication...

Press release        Ecully, July 11, 2024 – 6.30 p.m.Spineway organizes hands-on training on total disc replacement with its ESP prostheses at IRCAD in Strasbourg The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, organized a hands-on training workshop entitled “Hands-on Total Disc Replacement featuring ESP technology” at the Institut de Recherche contre les Cancers de l’Appareil Digestif (IRCAD) in Strasbourg on June 28, 2024. During the event, Spineway’s ESP prostheses (cervical and lumbar) were presented to 25 surgeons and professionals, with a presentation of the products, their indications and two surgical approach sessions. The training workshops took place at IRCAD in Strasbourg, renowned for the quality of its facilities and were led by renowned surgeons, Dr. Biren Desai (Germany),...

WARREN, N.J., July 11, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, today released a letter to stockholders highlighting recent achievements, growth plans, and consideration of a potential share buyback. Letter to Stockholders We are pleased to share our progress and next steps that underscore our commitment to advancing science to benefit patients and physicians while supporting our stockholder’s investment. Our lead product candidate TVGN 489, an investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocyte (CTL) immunotherapy, is progressing for the treatment of acute COVID-19 in vulnerable cancer patients....

Series RIKV 24 0918 RIKV 25 0115ISIN IS0000036200 IS0000036572Maturity Date 09/18/2024 01/15/2025Auction Date 07/15/2024 07/15/2024Settlement Date 07/17/2024 07/17/2024On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bills in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bills must be received by the Central Bank before 14:00 on the Settlement Date and the Bills will be delivered in electronic form on the same day. Further reference is made to the General Terms of Icelandic Treasury bills and General Terms of Auction for Treasury bills on the Government Debt Management website. For additional information please contact Magnús Freyr Hrafnsson, Government Debt Management, at +354 569 9679.

Oxurion provides clarification on the agenda of the extraordinary general shareholders’ meeting to be held on 24 July 2024 Leuven, BELGIUM – July 11, 2024 – 6:00pm CET – Oxurion NV (Euronext Brussels: OXUR), an innovative biopharmaceutical company based in Leuven, announced today it has provided clarification on the agenda of the extraordinary general shareholders’ meeting to be held on 24 July 2024 (the EGM) as set out in the convening notice published on 5 July 2024 in accordance with applicable laws. The EGM shall deliberate and vote on a potential share consolidation in respect of all outstanding shares of the Company by means of a 1-for-10,000 share and resulting authorization to the board of directors of the Company to further implement the share consolidation during a three-year period following the date of the EGM. The...

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 3 957 404,44 €Siège social : 1, Cours Antoine Guichard42000 Saint-Etienne554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de voteet d’actions composant le capital socialau 30 juin 2024 (article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)Nombre d’actions composant le capital Nombre total de droits de vote Nombre total de droits de vote exerçables en assemblée générale400 939 713 401 401 335 401 376 507* * **  Fait le 11 juillet 2024 à 17h30AttachmentCasino_Nbre droits de vote et d’actions au 30-06-2024_Communiqué